KeenMind®
CLINICALLY RESEARCHED

Chronic Effects of KeenMind CDRI 08™ on Human Memory*

Abstract: The aim of this study was to examine the effects of an extract of Bacopa monnieri (KeenMind CDRI 08™) on cognitive function.

Methods: Seventy-six adults aged between 40 and 65 years took part in a double-blind randomized, placebo control study in which various memory functions were tested. There were three testing sessions: one prior to the trial, one after three months on the trial, and one six weeks after the completion of the trial.

Results: Significant effect of KeenMind on a test for the retention of new information. Follow-up tests showed that the rate of learning was unaffected, suggesting that KeenMind decreases the rate of forgetting of newly acquired information.

Conclusions: There was a significant effect on a task requiring the retention of new information: the recall of unrelated word pairs after a short delay. The effect appears to be a reduction in the amount of information lost from memory. When combined with the finding of improved retention of information in this study, this suggests that the effect of KeenMind may be mediated by antioxidant action within the hippocampus.

*Roodenrys S et al. 2002. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacol., 27: 279–281.

Go back to Clinical and Scientific Studies